Alcyone Therapeutics Inc., a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of therapies for complex neurological conditions, has officially...
Alcyone Therapeutics Inc., a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of therapies for complex neurological conditions, has officially...
BioVaxys Technology Corp, a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPXâ„¢ platform, has officially signed a Letter...
Options Medical Weight Loss, a Thurston Group portfolio company, has officially confirmed its achievement of significant revenue growth, translating to an uptick worth 80...
